Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, semaglutide and President and CEO
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns
Compounded versions of
semaglutide
, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief executive of Ozempic maker Novo Nordisk warned Wednesday.
Novo Nordisk CEO Warns of Deaths Linked to Compounded Semaglutide
Honestly, I’m quite alarmed by what we see in the U.S. now,” Novo Nordisk President and CEO Lars Fruergaard Jorgensen told CNN on Wednesday. “Patients who believe that they’re getting access to a safe product,
Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO
Novo Nordisk's CEO told CNN he is "alarmed" by the risks compounded versions of semaglutide — the active ingredient in the company's diabetes drug Ozempic and weight loss drug Wegovy — are posing to users.
First for Women on MSN
1d
Ozempic for Perimenopause? Ob-Gyn Explains How Semaglutide May Help
Semaglutide, the active ingredient in Ozempic, has shown promising results in weight loss and blood sugar management. But did ...
Hosted on MSN
3d
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down
The position was supported by the TRAVERSE trial findings. (Mayo Clinic Proceedings) All doses of
semaglutide
(Ozempic, ...
News Medical
16h
Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes
Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar ...
8d
7 common myths about semaglutide and weight loss debunked
Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug ...
Daily
10h
Injectable semaglutide may reduce body weight and knee osteoarthritis-associated pain: NEJM
A new study published in the New England Journal of Medicine showed that once-weekly injectable semaglutide led to ...
The New England Journal of Medicine
9d
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
Weight reduction has been shown to alleviate symptoms of osteoarthritis of the knee, including pain. The effect of ...
Medscape
1d
Does Semaglutide Increase Risk for Optic Neuropathy?
The use of
semaglutide
, a glucagon-like peptide 1 receptor agonist (GLP-1 RA), is not associated with an increased risk for ...
The American Journal of Managed Care
2d
Semaglutide Linked to Reduced Health Care Expenses for Patients With Obesity, HF, ASCVD
Results demonstrated the mean total medical costs per patient per year decreased significantly after patients began ...
Futurism on MSN
6d
Semaglutide So Effective at Treating Arthritis That Patients Were “More or Less Were Treated Out of the Study”
In a groundbreaking new study, the active ingredient in Ozempic was found to be so effective at treating arthritis that ...
Rolling Out
5d
7 exciting ways to reduce Alzheimer’s risk with semaglutide
For years, scientists have observed a connection between type 2 diabetes and an increased risk of dementia, particularly ...
11d
Does Compounded Semaglutide Work for Weight Loss?
Compounded semaglutide can be an affordable alternative to brand-name weight loss injections like Ozempic and Wegovy. But ...
The Hindu
1d
Has semaglutide transformed treatment of diabetes and obesity in India?
Ozempic, known generically as
semaglutide
, is an injectable prescription drug. It was approved in 2017 by the United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Novo Nordisk
Ozempic
Wegovy
ESSENCE trial
MASH
Feedback